fendiline has been researched along with Carcinoma, Hepatocellular in 1 studies
Fendiline: Coronary vasodilator; inhibits calcium function in muscle cells in excitation-contraction coupling; proposed as antiarrhythmic and antianginal agents.
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, JS | 1 |
| Wang, JL | 1 |
| Lo, YK | 1 |
| Chou, KJ | 1 |
| Lee, KC | 1 |
| Liu, CP | 1 |
| Chang, HT | 1 |
| Jan, CR | 1 |
1 other study available for fendiline and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Effects of the antianginal drug fendiline on Ca2+ movement in hepatoma cells.
Topics: Calcium; Calcium Channel Blockers; Carcinoma, Hepatocellular; Endoplasmic Reticulum; Fendiline; Huma | 2001 |